![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 2050-0904|3|9|731-734
ISSN: 2050-0904
Source: Clinical Case Reports, Vol.3, Iss.9, 2015-09, pp. : 731-734
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Use of Intravenous Immunoglobulin in Multiple Sclerosis
By Achiron A.
BioDrugs, Vol. 9, Iss. 6, 1998-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders
By Larroche C.
BioDrugs, Vol. 16, Iss. 1, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Intravenous Immunoglobulin Plus Interferon- in Autoimmune Hepatitis C
BioDrugs, Vol. 18, Iss. 1, 2004-01 ,pp. :